RE:EXACT SCIENCES COMPLETES ACQUISITION OF THRIVEMakes no sense that we would be sitting at a market cap of $44 million.
Exact Sciences Corp. (Nasdaq: EXAS) and Thrive Earlier Detection Corp. ("Thrive"), a healthcare company dedicated to incorporating earlier cancer detection into routine medical care, today announced they have entered into a definitive agreement under which Exact Sciences will acquire Thrive for cash and stock consideration of up to $2.15 billion. InvestManOne wrote: EXACT SCIENCES COMPLETES ACQUISITION OF THRIVE EARLIER
DETECTION, CREATING A LEADER IN BLOOD-BASED, MULTI-CANCER SCREENING JAN 5, 2021
https://money.tmx.com/en/quote/EXAS:US/news/6819844710375101/Exact_Sciences_Completes_Acquisition_of_Thrive_Earlier_Detection_Creating_a_Leader_in_BloodBased_MultiCancer_Screening